Lv3
278 积分 2024-06-20 加入
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
2天前
已完结
P90 Surgical outcomes after neoadjuvant nivolumab and platinum-based chemotherapy in resectable non-small cell lung cancer
4天前
求助中
EP.08D.09 Efficacy and Safety of Neoadjuvant Tislelizumab Plus Chemotherapy for the Treatment of Non-Small Cell Lung Cancer: a Pooled Analysis
5天前
已关闭
EP.07C.15 Neoadjuvant Immuno-Chemotherapy in Resectable Non-Small Cell Lung Cancer - A Retrospective Cohort Study
7天前
已关闭
MA01.05 Efficacy and Safety of Neoadjuvant Camrelizumab and Apatinib Combined with Chemotherapy in Stage IIIA (N2) NSCLC: A Single Arm, Phase II Trial
7天前
已关闭
MA01.04 AFT-46: CHIO3: Chemotherapy Combined with Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
9天前
已完结
EP.08A.03 Real World Outcomes of Adjuvant Atezolizumab in NSCLC: A Single Institution Study
15天前
已关闭
MA01.05 Efficacy and Safety of Neoadjuvant Camrelizumab and Apatinib Combined with Chemotherapy in Stage IIIA (N2) NSCLC: A Single Arm, Phase II Trial
15天前
已关闭
P3.08F.07 Efficacy and Safety of Envafolimab Plus Platinum-based Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB NSCLC
15天前
已关闭
Adjuvant and Neoadjuvant Immunotherapy in Non–small Cell Lung Cancer
16天前
已完结
皖公网安备34019202002308
